Related Experiment Videos
Hypertension in IgA nephropathy
Insights
Hypertension significantly impacts IgA nephritis patients, increasing risks of kidney damage and reducing renal survival. Controlling high blood pressure is crucial for slowing disease progression and preserving kidney function.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Immunoglobulin A (IgA) nephritis is a common cause of glomerulonephritis.
- Hypertension is a known risk factor for chronic kidney disease progression.
- The relationship between hypertension and IgA nephritis outcomes requires further elucidation.
Purpose of the Study:
- To investigate the impact of hypertension on the progression of IgA nephritis.
- To compare histological and clinical outcomes in hypertensive versus normotensive IgA nephritis patients.
- To assess the effect of hypertension control on renal survival in IgA nephritis.
Main Methods:
- Retrospective analysis of 151 IgA nephritis patients.
- Comparison of clinical, laboratory, and histological parameters between hypertensive and normotensive groups.
- Evaluation of renal survival rates and time to end-stage renal failure.
Main Results:
- Hypertensive IgA nephritis patients exhibited higher rates of glomerulosclerosis, vascular hypertrophy, tubular atrophy, and proteinuria.
- Chronic renal failure occurred more frequently in hypertensive patients (42%) versus normotensive patients (14%).
- Cumulative renal survival at 8 years was lower in hypertensive (78%) compared to normotensive (91%) patients (p<0.05).
- Uncontrolled hypertension accelerated progression to end-stage renal failure within 3 years.
Conclusions:
- Hypertension is associated with more severe histological damage and poorer renal outcomes in IgA nephritis.
- Controlling hypertension is critical for improving renal survival and slowing disease progression in IgA nephritis patients.
- Early detection and management of hypertension are essential for preserving kidney function.
Abstract:
Among 151 patients with IgA nephritis, 18/151 (12%) had hypertension at presentation and 50/151 (33%) were hypertensive after an interval of 65 +/- 40 (Mean +/- SD) months. Hypertensive patients (n = 50) had a higher incidence of glomerulosclerosis, medial hypertrophy of blood vessels, tubular atrophy, poorly selective proteinuria and extension of immunodeposits to peripheral capillary walls compared to normotensive patients (n = 101). Chronic renal failure occurred more commonly among hypertensives compared to normotensive patients (42%) versus 14%. However, the time taken for patients to reach renal impairment or end stage renal failure was not significantly different. The cumulative renal survival for the hypertensive group was 78% after 8 years compared to 91% in the normotensive group (p less than 0.05). In the second part of the study, patients who were hypertensive at presentation (n = 18) were compared with those who developed hypertension on follow up (n = 32). Apart from a shorter duration of follow up for patients with hypertension and a higher incidence of glomerulosclerosis, there were no significant differences in their clinical presentation, laboratory indices or other histological parameters. The incidence of chronic renal failure and the time taken to reach end stage renal failure were not different. Uncontrolled hypertension was an important cause for rapid deterioration to end stage renal failure within 3 years, compared to 8 years when hypertension was controlled.